Bristol-Myers recalls vials of cancer drug

(AP)—Bristol-Myers Squibb Co. is recalling more than 31,000 units of a chemotherapy drug after discovering one vial was overfilled, putting patients at risk of an overdose.

The company's action affects 10 lots of BiCNU, an injection of the drug carmustine, used to treat , multiple myeloma, Hodgkin's disease and non-Hodgkin's lymphoma.

Bristol-Myers said taking too much of the drug could result in lung or kidney toxicity, though no adverse events have been reported yet.

The drug was manufactured by Ben Venue Laboratories, a former manufacturing contractor for the New York drugmaker. The recall affects products sold in the U.S., Canada, Europe, Latin America and Asia.

Bristol-Myers said the recall is unlikely to result in a product shortage.

and customers can get more information by calling 1-888-896-4564.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Recommended for you

WHO: Millions of Ebola vaccine doses ready in 2015

12 hours ago

The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March.

Added benefit of vedolizumab is not proven

Oct 23, 2014

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments